Pfizer, Inc. (NYSE:PFE)
A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Recs
rurbey
(< 20)
Submitted: 1/17/2012 8:27:23 PM :
Start Price:
$21.03
PFE Score:
-2.58
good pipeline, well managed, safe dividend, aging population
Recs
Mainepilot
(< 20)
Submitted: 1/6/2012 11:15:57 AM :
Start Price:
$21.48
PFE Score:
-7.01
Dividends and covered call options.
Recs
Staka
(98.56)
Submitted: 12/31/2011 3:23:41 PM :
Start Price:
$21.27
PFE Score:
-7.65
Positive:
- Defensive Business
- Slightly expensive but with a good dividend
- 22 drugs in phase III, a total of 95 in the pipeline
Negative:
- Many hidden risks (law suits, FDA)
- Hugh revenue loss at the end of 2012, but this is a well known fact which should be priced in
- Chart somewhat overextended
Category: MT+
Recs
dulcie99
(42.34)
Submitted: 12/19/2011 9:06:31 PM :
Start Price:
$21.09
PFE Score:
-10.17
outperform
Recs
thstorm93
(60.15)
Submitted: 12/8/2011 12:42:29 AM :
Start Price:
$18.24
PFE Score:
+3.66
Expiring patents are already priced in so that will have no effect on their stock price. They have a history of creating blockbuster drugs and there are more to come as they currently have 118 drugs in the pipeline. 60 of those are in phase 2 or 3. Last year they surpassed $1 billion in annual revenue in both China and Brazil for the first time in the company’s history. These are two of the largest emerging pharmaceutical markets globally so continued growth is expected. This is a dependable, low risk company, with growth potential and a great dividend. OUTPERFORM!!!
Recs
tbonci
(66.48)
Submitted: 11/26/2011 12:02:09 PM :
Start Price:
$18.62
PFE Score:
+0.67
Huge pharma company with over a dozen household name brands, who have managed to grow operating margins. A health care giant who is well positioned to support the growing/aging population.
Recs
stockstar69
(23.72)
Submitted: 11/21/2011 2:06:52 PM :
Start Price:
$18.83
PFE Score:
-0.86
Still a good dividend, good research pipeline and lots of cash.
Recs
TMFDitty
(99.48)
Submitted: 11/15/2011 11:21:50 AM :
Start Price:
$19.61
PFE Score:
-0.15
8x FCF seems a fair price to pay for 4% growth and a 4% divvy. I'll take that offer.
Recs
BinyaminK
(21.70)
Submitted: 11/9/2011 1:47:16 PM :
Start Price:
$19.26
PFE Score:
+1.04
This is a "Giant Tortoise Stock." Like a giant tortoise, It may be big and slow, but it has a hard shell (economic moat), can swim far (enter into new and emerging markets and industries), and live long.
Recs
gtnuno
(41.55)
Submitted: 11/7/2011 10:28:56 AM :
Start Price:
$19.31
PFE Score:
-1.59
Expiring patents
Recs
hurricanehedge
(47.20)
Submitted: 11/7/2011 10:16:20 AM :
Start Price:
$19.37
PFE Score:
+1.53
Let all their other drugs disappear are consumers ever going to stop using Advil and robitussin? The answer is no.
Recs
ryatin
(< 20)
Submitted: 10/28/2011 12:17:23 PM :
Start Price:
$19.37
PFE Score:
+3.87
Patents for several household name drugs expire before end of 2013 with no large market drugs in pipeline until 2015 and those still await FDA approval. Short-term gain likely with a possible long term gain, but mid-range a virtually loss assured.
Recs
RenoNV
(53.82)
Submitted: 10/17/2011 1:10:12 AM :
Start Price:
$18.58
PFE Score:
+2.33
Undervalued with good dividend.
Recs
mikemariani
(66.44)
Submitted: 9/30/2011 10:39:44 AM :
Start Price:
$17.48
PFE Score:
+3.03
magic formula
Recs
Palido
(53.52)
Submitted: 9/27/2011 4:09:59 PM :
Start Price:
$17.40
PFE Score:
+6.87
Decent dividend, fairly priced.
Recs
Tony007x
(53.64)
Submitted: 9/24/2011 3:39:51 AM :
Start Price:
$17.05
PFE Score:
-6.22
expecting PFE to fall couple of weeks before rebounding
Recs
Danpines
(43.74)
Submitted: 9/18/2011 8:40:24 AM :
Start Price:
$17.43
PFE Score:
+13.13
Great undervalued company. They have items comming off patent which is priced in the stock share.
Recs
Recs
The1ntervention
(< 20)
Submitted: 8/18/2011 12:15:12 PM :
Start Price:
$17.58
PFE Score:
+3.19
The new JAK rheumatoid drugs look promising and a lot of people would love to have an oral medication that can be used with or after failure of MTX.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 991 : 1 2 3 4 5 6 7 8 9 10 Next »